Psychiatric Clearance for Patients Started on Interferon-Alpha-Based Therapies
- 1 June 2013
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 170 (6) , 592-597
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Early activation of p38 mitogen activated protein kinase is associated with interferon-alpha-induced depression and fatigueBrain, Behavior, and Immunity, 2011
- Labile Anger During Interferon Alfa Treatment is Associated With a Polymorphism in Tumor Necrosis Factor αClinical Neuropharmacology, 2010
- Poor sleep quality predicts onset of either major depression or subsyndromal depression with irritability during interferon-alpha treatmentPsychiatry Research, 2010
- Phospholipase A2 and Cyclooxygenase 2 Genes Influence the Risk of Interferon-α–Induced Depression by Regulating Polyunsaturated Fatty Acids LevelsBiological Psychiatry, 2010
- Cytokine-induced depression during IFN-α treatment: The role of IL-6 and sleep qualityBrain, Behavior, and Immunity, 2009
- Risk for Depression During Interferon-Alpha Treatment Is Affected by the Serotonin Transporter PolymorphismBiological Psychiatry, 2009
- Exercise Training and Plasma C‐Reactive Protein and Interleukin‐6 in Elderly PeopleJournal of the American Geriatrics Society, 2008
- Exercise but not diet-induced weight loss decreases skeletal muscle inflammatory gene expression in frail obese elderly personsJournal of Applied Physiology, 2008
- Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-α and ribavirin treatmentMolecular Psychiatry, 2008
- Depression following pegylated interferon-alpha: Characteristics and vulnerabilityJournal of Psychosomatic Research, 2007